17627 results
-
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency (updated)
Date of first decision: 20/03/2007, Positive, Last updated: 20/10/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RCP FeLV (updated)
Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline Calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), Cats
Date of authorisation: 23/02/2005, Revision: 12, Authorised, Last updated: 20/10/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RC (updated)
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) / inactivated feline calicivirosis antigens (FCV 431 and G1 strains), Cats
Date of authorisation: 23/02/2005, Revision: 13, Authorised, Last updated: 20/10/2020 -
List item
Scientific publications (updated)
Last updated: 20/10/2020 -
List item
Referral: Angiotensin-II-receptor antagonists (sartans) containing a tetrazole group (updated)
valsartan, candesartan, irbesartan, losartan and olmesartan, associated names: Karvezide, Karvea, Irbesartan/Hydrochlorothiazide Teva, Irbesartan Zentiva (previously Irbesartan Winthrop), Irbesartan Teva, Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), Ifirmasta (previously Irbesartan Krka), Ifirmacombi, Aprovel, Neparvis, Exforge, Exforge HCT, Entresto, Dafiro HCT, Dafiro, Copalia HCT, Copalia, Amlodipine / Valsartan Mylan , CoAprovel, Article 31 referrals
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 02/04/2019, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Pfizer (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 10/04/2014, Revision: 20, Authorised, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): SomaKit TOC (updated)
edotreotide, Neuroendocrine Tumors, Radionuclide Imaging
Date of authorisation: 08/12/2016,
, 
, Revision: 6, Authorised, Last updated: 20/10/2020
-
List item
Herbal medicinal product: Tanaceti parthenii herba (updated)
Tanacetum parthenium (L.) Schultz Bip., Feverfew, F: Assessment finalised, Last updated: 20/10/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Oxyglobin (updated)
haemoglobin glutamer-200 (bovine), Dogs
Date of authorisation: 29/11/1999, Revision: 16, Authorised, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): Skyrizi (updated)
Risankizumab, Psoriasis
Date of authorisation: 26/04/2019,, Revision: 3, Authorised, Last updated: 20/10/2020
-
List item
Human medicine European public assessment report (EPAR): Viekirax (updated)
Ombitasvir, paritaprevir, ritonavir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, 
, Revision: 21, Authorised, Last updated: 20/10/2020
-
List item
Human medicine European public assessment report (EPAR): Naglazyme (updated)
galsulfase, Mucopolysaccharidosis VI
Date of authorisation: 23/01/2006,, 
, Revision: 17, Authorised, Last updated: 20/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ucedane (updated)
carglumic acid, Hyperammonemia, Amino Acid Metabolism, Inborn Errors
Date of authorisation: 23/06/2017,
, Revision: 6, Authorised, Last updated: 20/10/2020
-
List item
Human medicine European public assessment report (EPAR): Obizur (updated)
susoctocog alfa, Hemophilia A
Date of authorisation: 11/11/2015,, , Revision: 5, Authorised, Last updated: 20/10/2020
-
List item
Medicine evaluation figures (updated)
Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): Constella (updated)
linaclotide, Irritable Bowel Syndrome
Date of authorisation: 26/11/2012, Revision: 20, Authorised, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): Abilify (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 04/06/2004, Revision: 47, Authorised, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): Tevagrastim (updated)
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,
, Revision: 13, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, , Revision: 5, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ratiograstim (updated)
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,, Revision: 12, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Xeljanz (updated)
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,
, , Revision: 13, Authorised, Last updated: 19/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jivi (updated)
Damoctocog alfa pegol, Hemophilia A
Date of authorisation: 22/11/2018,, Revision: 2, Authorised, Last updated: 19/10/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Aivlosin (updated)
tylvalosin, Pheasants, Chicken, Turkeys, Pigs
Date of authorisation: 09/09/2004, Revision: 30, Authorised, Last updated: 19/10/2020 -
List item
News: EMA virtual conference: 25 years of advancing public and animal health
Last updated: 19/10/2020 -
List item
Human medicine European public assessment report (EPAR): VeraSeal (updated)
human fibrinogen, human thrombin, Hemostasis, Surgical
Date of authorisation: 10/11/2017,, Revision: 3, Authorised, Last updated: 19/10/2020